Alnylam Pharmaceuticals
ALNY
#649
Rank
HK$305.08 B
Marketcap
HK$2,285
Share price
-0.61%
Change (1 day)
-10.73%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company